{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:36:21Z","timestamp":1793694981534,"version":"4.5.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06188-9","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T13:00:21Z","timestamp":1745240421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genetic characterization of BRCA1 and BRCA2 variants in cancer and high-risk family screening cohorts in the UAE population"],"prefix":"10.1007","volume":"151","author":[{"given":"Abeer Arif Abdalla Abutalib","family":"Al Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moza Mohamed Alechleh","family":"Al Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia Mahmoud Abdel-Hamid","family":"El-Shourbagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Hammad Hassan","family":"Tirmazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsheen","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Farooq","family":"Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemad","family":"Yasaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"1","key":"6188_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12885-018-4079-1","volume":"18","author":"H Abdel-Razeq","year":"2018","unstructured":"Abdel-Razeq H, Al-Omari A, Zahran F, Arun B (2018) Germline BRCA1\/BRCA2 mutations among high risk breast cancer patients in Jordan. BMC Cancer 18(1):152","journal-title":"BMC Cancer"},{"issue":"1","key":"6188_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12885-019-5463-1","volume":"19","author":"K Abdulrashid","year":"2019","unstructured":"Abdulrashid K, AlHussaini N, Ahmed W, Thalib L (2019) Prevalence of BRCA mutations among hereditary breast and\/or ovarian cancer patients in Arab countries: systematic review and meta-analysis. BMC Cancer 19(1):256","journal-title":"BMC Cancer"},{"issue":"1","key":"6188_CR3","doi-asserted-by":"publisher","first-page":"17573","DOI":"10.1038\/s41598-020-74250-2","volume":"10","author":"M Abu-Helalah","year":"2020","unstructured":"Abu-Helalah M, Azab B, Mubaidin R, Ali D, Jafar H, Alshraideh H et al (2020) BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan. Sci Rep 10(1):17573","journal-title":"Sci Rep"},{"issue":"5","key":"6188_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.21037\/cco-19-204","volume":"10","author":"O Abulkhair","year":"2021","unstructured":"Abulkhair O, El Saghir NS (2021) BReast CAncer gene (BRCA): snapshot of the Middle East. Chin Clin Oncol 10(5):51","journal-title":"Chin Clin Oncol"},{"issue":"1","key":"6188_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12885-021-09123-6","volume":"22","author":"N Agha","year":"2022","unstructured":"Agha N, Alshamsan B, Al-Farsi S, Ateya HA, Almugbel FA, Alotaibi HA et al (2022) Assessing frequency and clinical outcomes of BRCA mutated ovarian cancer in Saudi women. BMC Cancer 22(1):18","journal-title":"BMC Cancer"},{"issue":"3","key":"6188_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.15406\/jcpcr.2018.09.00334","volume":"9","author":"HOAS Al-Shamsi","year":"2018","unstructured":"Al-Shamsi HOAS (2018) Breast cancer screening in the United Arab Emirates: is it time to call for a screening at an earlier age? J Cancer Prev Curr Res 9(3):123\u2013126","journal-title":"J Cancer Prev Curr Res"},{"issue":"11","key":"6188_CR7","doi-asserted-by":"publisher","first-page":"e2086","DOI":"10.1002\/onco.13916","volume":"26","author":"HO Al-Shamsi","year":"2021","unstructured":"Al-Shamsi HO, Abu-Gheida I, Abdulsamad AS, AlAwadhi A, Alrawi S, Musallam KM et al (2021) Molecular spectra and frequency patterns of somatic mutations in Arab women with breast cancer. Oncologist 26(11):e2086\u2013e2089","journal-title":"Oncologist"},{"key":"6188_CR8","doi-asserted-by":"publisher","DOI":"10.1200\/GO.22.00247","volume":"9","author":"HO Al-Shamsi","year":"2023","unstructured":"Al-Shamsi HO, Abdelwahed N, Al-Awadhi A, Albashir M, Abyad AM, Rafii S et al (2023) Breast cancer in the United Arab Emirates. JCO Glob Oncol 9:e2200247","journal-title":"JCO Glob Oncol"},{"key":"6188_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.breast.2020.07.005","volume":"53","author":"A Altinoz","year":"2020","unstructured":"Altinoz A, Al Ameri M, Qureshi W, Boush N, Nair SC, Abdel-Aziz A (2020) Clinicopathological characteristics of gene-positive breast cancer in the United Arab Emirates. Breast 53:119\u2013124","journal-title":"Breast"},{"issue":"3","key":"6188_CR10","volume":"16","author":"MA Ameri","year":"2024","unstructured":"Ameri MA, Shanbhag NM, Bin Sumaida A, Ansari J, Trad DA, Dawoud EA et al (2024) Oncotype DX in Breast Cancer Management: Insights and Outcomes From the United Arab Emirates. Cureus 16(3):e56535","journal-title":"Cureus"},{"issue":"4","key":"6188_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/ijc.32176","volume":"145","author":"SP Bhaskaran","year":"2019","unstructured":"Bhaskaran SP, Chandratre K, Gupta H, Zhang L, Wang X, Cui J et al (2019) Germline variation in BRCA1\/2 is highly ethnic-specific: evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients. Int J Cancer 145(4):962\u2013973","journal-title":"Int J Cancer"},{"issue":"5","key":"6188_CR12","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/ijc.30143","volume":"139","author":"R Bu","year":"2016","unstructured":"Bu R, Siraj AK, Al-Obaisi KA, Beg S, Al Hazmi M, Ajarim D et al (2016) Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis. Int J Cancer 139(5):1091\u20131097","journal-title":"Int J Cancer"},{"key":"6188_CR13","doi-asserted-by":"crossref","unstructured":"Dawood SS, Apessos A, Elkhoury M, Khan F, Khatib F, Bello M, et al. Analysis of hereditary cancer syndromes in patients from the United Arab Emirates. Journal of Clinical Oncology. 2018;36(15_suppl):e13509-e.","DOI":"10.1200\/JCO.2018.36.15_suppl.e13509"},{"key":"6188_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.18632\/oncotarget.28561","volume":"15","author":"E De Matteis","year":"2024","unstructured":"De Matteis E, Tumolo MR, Tarantino P, Ciccarese M, Grassi T, Bagordo F et al (2024) Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health. Oncotarget 15:134\u2013141","journal-title":"Oncotarget"},{"issue":"2","key":"6188_CR15","first-page":"253","volume":"51","author":"K El Goundali","year":"2022","unstructured":"El Goundali K, Chebabe M, Zahra Laamiri F, Hilali A (2022) The determinants of consanguineous marriages among the arab population: a systematic review. Iran J Public Health 51(2):253\u2013265","journal-title":"Iran J Public Health"},{"issue":"7035","key":"6188_CR16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB et al (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434(7035):917\u2013921","journal-title":"Nature"},{"issue":"2","key":"6188_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5306\/wjco.v14.i2.40","volume":"14","author":"EN Imyanitov","year":"2023","unstructured":"Imyanitov EN, Kuligina ES, Sokolenko AP, Suspitsin EN, Yanus GA, Iyevleva AG et al (2023) Hereditary cancer syndromes. World J Clin Oncol 14(2):40\u201368","journal-title":"World J Clin Oncol"},{"issue":"11","key":"6188_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1002\/humu.23842","volume":"40","author":"Y Laitman","year":"2019","unstructured":"Laitman Y, Friebel TM, Yannoukakos D, Fostira F, Konstantopoulou I, Figlioli G et al (2019) The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries. Hum Mutat 40(11):e1\u2013e23","journal-title":"Hum Mutat"},{"issue":"6","key":"6188_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/13543784.2022.2067527","volume":"31","author":"L Luo","year":"2022","unstructured":"Luo L, Keyomarsi K (2022) PARP inhibitors as single agents and in combination therapy: the most promising treatment strategies in clinical trials for BRCA-mutant ovarian and triple-negative breast cancers. Expert Opin Investig Drugs 31(6):607\u2013631","journal-title":"Expert Opin Investig Drugs"},{"key":"6188_CR20","unstructured":"National Comprehensive Cancer Network (NCCN) https:\/\/www.nccn.org\/guidelines\/nccn-guidelines."},{"issue":"8","key":"6188_CR21","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/pros.23795","volume":"79","author":"M Oh","year":"2019","unstructured":"Oh M, Alkhushaym N, Fallatah S, Althagafi A, Aljadeed R, Alsowaida Y et al (2019) The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: a meta-analysis. Prostate 79(8):880\u2013895","journal-title":"Prostate"},{"key":"6188_CR22","unstructured":"ONCOLOGY NCPGI. Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021."},{"key":"6188_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.gene.2018.05.045","volume":"668","author":"S Rahman","year":"2018","unstructured":"Rahman S, Zayed H (2018) Breast cancer in the GCC countries: A focus on BRCA1\/2 and non-BRCA1\/2 genes. Gene 668:73\u201376","journal-title":"Gene"},{"issue":"5","key":"6188_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17(5):405\u2013424","journal-title":"Genet Med"},{"key":"6188_CR25","unstructured":"Shelpai W. Cancer incidence in United Arab Emirates annual report of the UAE\u2014National cancer registry MOHAP: MOHAP; 2019 www.mohap.gov.ae."},{"issue":"3","key":"6188_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"6188_CR27","unstructured":"WHO IAfRoC. 2024 https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/784-united-arab-emirates-fact-sheet.pdf."},{"key":"6188_CR28","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.2147\/CMAR.S211151","volume":"12","author":"W Wong","year":"2020","unstructured":"Wong W, Raufi AG, Safyan RA, Bates SE, Manji GA (2020) BRCA mutations in pancreas Cancer: spectrum, current management, challenges and future prospects. Cancer Manag Res 12:2731\u20132742","journal-title":"Cancer Manag Res"},{"key":"6188_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.gene.2018.10.044","volume":"684","author":"N Younes","year":"2019","unstructured":"Younes N, Zayed H (2019) Genetic epidemiology of ovarian cancer in the 22 Arab countries: a systematic review. Gene 684:154\u2013164","journal-title":"Gene"},{"key":"6188_CR30","unstructured":"Z S. Prevalance of BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Northern Emirates UAE University; 2020."}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06188-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06188-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06188-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T02:50:37Z","timestamp":1747104637000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06188-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["6188"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06188-9","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for this study was obtained from the Dubai Scientific Research Ethics Committee (DSREC), Dubai Health Authority, under reference number DSREC-07\/2022_14. This research was conducted in full adherence to the principles outlined in the Declaration of Helsinki. All participants provided informed consent, including consent for genetic research and publication purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"146"}}